F.A.Z. Wissen

FAZ Wissen Die Links und Paper zu diesem Podcast: EMA, 25.10.2021:"COVID-19: EMA starts rolling review of molnupiravir" Merck Pressemitteilung vom 1. Oktober Vfa v. 25.=ktober 2021: Therapeutische Medikamente gegen die Coronavirusinfektion Covid-19 Andrew Hill et al, Research Square, Preprint (!): "Ivermectin for COVID-19: addressing potential bias and medical fraud" Agatha Mikolajewska et al, Cochrane Library Review, "Colchicine for the treatment of COVID‐19"

FAZ Wissen Nature Artikel: Bianca Nogrady: "‘I hope you die’: how the COVID pandemic unleashed attacks on scientists", 13.10.2021 Daten der Umfrage Wissenschaftler-Statements des deutschen SMC zum Nature-Artikel Wissenschaftler-Statements des britischen SMC zum Nature-Artikel

FAZ Wissen Die Paper zu dieser Podcast-Folge: Shup Feng et al, Nature Medicine, 2021, "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection" Gesellschaft für Virologie, 2021, "Aktualisierte Stellungnahme zur Immunität von Genesenen" Einav Levin et al, NEJM, 2021, "Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months" Sarah Tartof et al, Lancet, 2021, "Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study" Maya Poon et al, Science Immunology, 2021, "SARS-CoV-2 infection generates tissue-localized immunological memory in humans" Elizabeth Anderson et al, medRxiv (Preprint), 2021, "SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared to SARS-CoV-2 mRNA vaccinations"

F.A.Z. Wissen Nature Studie zum Einsatz von KI bei der Einreise nach Griechenland: H. Bastani et al. "Efficient and targeted COVID-19 border testing via reinforcement learning", Nature, 22.9.2021 Kommentar zur Studie: Z. Obermeyer: "A machine-learning algorithm to target COVID testing of travellers", Nature, 22.9.21 Britische Studie zur Identifikation von Covid-19-Erkrankungen auf der Grundlage früher Symptome: L.S. Canas et al. "Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study", The Lancet Digital Health, 1.9.2021 KI im Einsatz zur Vorhersage der Eigenschaften von Virusvarianten: C. Chen et al.: "Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2", PNAS, 23.8.21

FAZ Wissen Die Paper zu dieser Podcast-Folge: Stratil JM et al, Cochrane Review, 2021, "Non-pharmacological measures implemented in the setting oflong-term care facilities to prevent SARS-CoV-2 infections and theirconsequences: a rapid review (Review)" RKI-Papier: "Aktualisierung der ControlCOVID-Strategie zur Vorbereitung auf den Herbst/Winter 2021/22" vom 22. September 2021 Julian Hirt et al, F1000Research (Preprint), 2021, "Clinical trial research on COVID-19 in Germany – a systematic analysis"

FAZ Wissen Die Publikationen zu dieser Podcast-Folge: Science Media Center (SMC), Press Briefing, Transkript, 13. Sept. 2021, "Die deutsche Impfkampagne stockt –Gründe, Lösungen, Perspektiven" SMC-Briefing, Videomitschnitt, Youtoube: https://www.youtube.com/watch?v=vXOQcr6kE68 Mark Navin, Social Theory and Practise, 2013, "Competing Epistemic Spaces: How Social Epistemology Helps Explain and Evaluate Vaccine Denialism"

FAZ Wissen Die Paper zu dieser Podcast-Folge: Terence Stephenson et al, Preprint, Research Square, 2021, "Long COVID - the physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study" CDC Morbidity and Mortality Weekly Report (MMWR), Weekly, 2021, "Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021" Simriti Malapaty, Nature, 2021, "Kids and COVID: why young immune systems are still on top" Longcovid-Informationsseite (in Englisch):- "Long Covid Kids"

FAZ Wissen Die Paper zu dieser Podcast-Folge: Stefan Moritz et al, Nature Communications, 2021, "The risk of indoor sports and culture events for the transmission of COVID-19" Jenifer A.E. Smith et al, Preprint, 2021, "Public health impact of mass sporting and cultural events in a rising COVID-19 prevalence in England" Boris Revollo et al, Lancet, 2021, "Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial" Josep Llibre et al, Annals of Internal Medicine, 2021, "Screening for SARS-CoV-2 Antigen Before a Live Indoor Music Concert: An Observational Study" F.A.Z.-Artikel: Sibylle Anderl vom 25. August 2021, "Wie gefährlich sind Großveranstaltungen?"

FAZ Wissen Wirken die Impfungen auch gegen Delta? Englische Studie: J. Bernal et al., 21.7.21, "Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant", NEJM Schottische Studie mit Hospitalisierungsangaben: A. Sheikh et al., 26.6.21, "SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness", The Lancet Können Geimpfte Überträger sein? C. Brown et al., 30.7.21, "Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021", Morbidity and Mortality Weekly Report (MMWR), CDC Preprint vom Imperial College: P. Elliott et al., "REACT-1 round 13 final report: exponential growth,high prevalence of SARS-CoV-2and vaccine effectiveness associated with Delta variantin England during May to July2021", Preprint Israelische Studie: M. Bergwerk et al., 28.7.21., "Covid-19 Breakthrough Infections in Vaccinated Health Care Workers", NEJM Studie zur Verbreitung von Delta in den USA: A. Bolze et al., 21.6.21, "Rapid displacement of SARS-CoV-2 variant B.1.1.7 by B.1.617.2 and P.1 in the United States", Preprint Tausendfache Virenlast: B. Li et al., 23.7.21, "Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant", Preprint Preprint aus Singapur, Po Yin Chia et al, 31.7.21, „Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study“, medRxiv Preprint zur Lambda-Variante, Izumi Kimura et al, "SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance", bioRxiv

FAZ Wissen Die Paper zu dieser Podcast-Folge: Craig Fenwick et al, Science Translational Medicine, 2021, "A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma" Dung Nguyen et al, Eurosurveillance, 2021, "SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data" Preprint (!): Judith Kannenberg et al, medRxiv, 2021, "Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera" Positionspapier des Verbands der Diagnostica-Industrie, 2021, "Antikörpertestung förderteffiziente Impfstrategien gegen COVID-19. Impferfolg beschleunigen + Vertrauen erhöhen + Wissenverbessern"